AR019279A1 - Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion. - Google Patents
Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion.Info
- Publication number
- AR019279A1 AR019279A1 ARP990102177A ARP990102177A AR019279A1 AR 019279 A1 AR019279 A1 AR 019279A1 AR P990102177 A ARP990102177 A AR P990102177A AR P990102177 A ARP990102177 A AR P990102177A AR 019279 A1 AR019279 A1 AR 019279A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- preparation
- salts
- pharmaceutically applicable
- oral application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forma medicamentosa solida de estructura polifásica para aplicacion oral, que consiste en gatifloxacina o sus sales o hidratos farmacéuticamente aplicables, y auxiliares elegidos del grupo que comprende cargas, aglutinantes, lubricantes, promotoresd e disgregacion o sus mezclas, que comprende una fase interior quecontiene la sustancia activa gatifloxacina o sus sales o hidratos farmacéuticamente aplicables, auxiliares elegidos del grupo que comprende aglutinantes,cargas, promotores dedisgregaci on o sus mezclas, y al menos una fase exterior que contiene como componente necesario al menos un promotor de disgregacion, yotros auxiliares elegidos del grupo que comprende al menos un lubricante, y eventualmente cargas y/oeventualmente aglutinant es. Procedimietno para lapreparacion de la forma medicamentosa solida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19820801A DE19820801A1 (de) | 1998-05-09 | 1998-05-09 | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019279A1 true AR019279A1 (es) | 2002-02-13 |
Family
ID=7867223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102177A AR019279A1 (es) | 1998-05-09 | 1999-05-07 | Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6291462B1 (es) |
| EP (1) | EP1077703B1 (es) |
| JP (1) | JP2002514600A (es) |
| KR (1) | KR100587210B1 (es) |
| CN (1) | CN1198615C (es) |
| AR (1) | AR019279A1 (es) |
| AT (1) | ATE235242T1 (es) |
| AU (1) | AU753482B2 (es) |
| BR (1) | BR9910350A (es) |
| CA (1) | CA2325636A1 (es) |
| CO (1) | CO5050341A1 (es) |
| DE (2) | DE19820801A1 (es) |
| DK (1) | DK1077703T3 (es) |
| ES (1) | ES2195573T3 (es) |
| HK (1) | HK1033281A1 (es) |
| HU (1) | HUP0101597A3 (es) |
| IL (1) | IL139512A0 (es) |
| MY (1) | MY118569A (es) |
| NO (1) | NO20005385L (es) |
| NZ (1) | NZ507968A (es) |
| PE (1) | PE20000480A1 (es) |
| PL (1) | PL343936A1 (es) |
| PT (1) | PT1077703E (es) |
| RU (1) | RU2226394C2 (es) |
| SK (1) | SK16772000A3 (es) |
| UA (1) | UA60364C2 (es) |
| WO (1) | WO1999058129A1 (es) |
| ZA (1) | ZA200006440B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU773218B2 (en) * | 1999-10-08 | 2004-05-20 | Debiopharm International Sa | Fab I inhibitors |
| US6413969B1 (en) * | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
| DE60230934D1 (de) * | 2001-04-06 | 2009-03-05 | Affinium Pharm Inc | Fab-i-inhibitoren |
| US6589955B2 (en) * | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| JP4859460B2 (ja) * | 2002-12-06 | 2012-01-25 | アフィニウム ファーマシューティカルズ， インク． | ヘテロ環化合物、その製造方法および治療におけるその使用 |
| CA2519429C (en) | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
| US20050031683A1 (en) * | 2003-08-04 | 2005-02-10 | Ashish Kapoor | Solid pharmaceutical composition |
| WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
| AR048431A1 (es) * | 2004-03-17 | 2006-04-26 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
| WO2007053131A2 (en) | 2004-06-04 | 2007-05-10 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as antibiotic agents |
| US20060247255A1 (en) * | 2005-05-02 | 2006-11-02 | Patel Satishkumar A | Method for preparing a stable gatifloxacin composition |
| EP1909736B1 (en) * | 2005-08-02 | 2014-11-12 | Baxter International Inc. | Oxygen indicator for use in medical products and packet containing oxygen indicator |
| CA2632476A1 (en) * | 2005-12-05 | 2007-06-14 | Affinium Pharmaceuticals, Inc. | Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| CA2658506C (en) | 2006-07-20 | 2016-01-26 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab 1 inhibitors |
| CN100415212C (zh) * | 2006-07-21 | 2008-09-03 | 哈药集团制药总厂 | 一种含乳酸卡德沙星的口服制剂 |
| CA2563690C (en) * | 2006-10-12 | 2014-10-07 | Pharmascience Inc. | Pharmaceutical compositions comprising intra- and extra- granular fractions |
| WO2008098374A1 (en) * | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
| WO2013190384A1 (en) | 2012-06-19 | 2013-12-27 | Affinium Pharmaceuticals, Inc. | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| MX2018010254A (es) | 2016-02-26 | 2018-12-19 | Debiopharm Int Sa | Medicamento para el tratamiento de infecciones de pie diabetico. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| AU653203B2 (en) * | 1991-01-30 | 1994-09-22 | Wellcome Foundation Limited, The | Water-dispersible tablets |
| GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
| US5436253A (en) * | 1993-09-08 | 1995-07-25 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives and mycotic infections |
| ES2210321T3 (es) * | 1994-12-19 | 2004-07-01 | Daiichi Pharmaceutical Co., Ltd. | Preparacion granular de liberacion prolongada y procedimiento de produccion. |
| US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
-
1998
- 1998-05-09 DE DE19820801A patent/DE19820801A1/de not_active Withdrawn
-
1999
- 1999-04-22 MY MYPI99001588A patent/MY118569A/en unknown
- 1999-04-29 DK DK99923491T patent/DK1077703T3/da active
- 1999-04-29 IL IL13951299A patent/IL139512A0/xx unknown
- 1999-04-29 AU AU40352/99A patent/AU753482B2/en not_active Ceased
- 1999-04-29 RU RU2000130202/15A patent/RU2226394C2/ru not_active IP Right Cessation
- 1999-04-29 HU HU0101597A patent/HUP0101597A3/hu unknown
- 1999-04-29 PT PT99923491T patent/PT1077703E/pt unknown
- 1999-04-29 UA UA2000126915A patent/UA60364C2/uk unknown
- 1999-04-29 CA CA002325636A patent/CA2325636A1/en not_active Abandoned
- 1999-04-29 NZ NZ507968A patent/NZ507968A/xx unknown
- 1999-04-29 EP EP99923491A patent/EP1077703B1/de not_active Expired - Lifetime
- 1999-04-29 AT AT99923491T patent/ATE235242T1/de not_active IP Right Cessation
- 1999-04-29 JP JP2000547980A patent/JP2002514600A/ja active Pending
- 1999-04-29 BR BR9910350-8A patent/BR9910350A/pt not_active IP Right Cessation
- 1999-04-29 KR KR1020007012442A patent/KR100587210B1/ko not_active IP Right Cessation
- 1999-04-29 SK SK1677-2000A patent/SK16772000A3/sk unknown
- 1999-04-29 WO PCT/EP1999/002893 patent/WO1999058129A1/de active IP Right Grant
- 1999-04-29 US US09/700,055 patent/US6291462B1/en not_active Expired - Fee Related
- 1999-04-29 DE DE59904737T patent/DE59904737D1/de not_active Expired - Fee Related
- 1999-04-29 PL PL99343936A patent/PL343936A1/xx unknown
- 1999-04-29 CN CNB998059897A patent/CN1198615C/zh not_active Expired - Fee Related
- 1999-04-29 ES ES99923491T patent/ES2195573T3/es not_active Expired - Lifetime
- 1999-05-03 PE PE1999000361A patent/PE20000480A1/es not_active Application Discontinuation
- 1999-05-04 CO CO99027132A patent/CO5050341A1/es unknown
- 1999-05-07 AR ARP990102177A patent/AR019279A1/es active IP Right Grant
-
2000
- 2000-10-26 NO NO20005385A patent/NO20005385L/no not_active Application Discontinuation
- 2000-11-08 ZA ZA200006440A patent/ZA200006440B/en unknown
-
2001
- 2001-06-14 HK HK01104097A patent/HK1033281A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005385D0 (no) | 2000-10-26 |
| CO5050341A1 (es) | 2001-06-27 |
| KR20010043408A (ko) | 2001-05-25 |
| EP1077703B1 (de) | 2003-03-26 |
| IL139512A0 (en) | 2001-11-25 |
| PT1077703E (pt) | 2003-08-29 |
| NO20005385L (no) | 2000-10-26 |
| AU4035299A (en) | 1999-11-29 |
| CN1198615C (zh) | 2005-04-27 |
| DE59904737D1 (de) | 2003-04-30 |
| US6291462B1 (en) | 2001-09-18 |
| DE19820801A1 (de) | 1999-11-25 |
| JP2002514600A (ja) | 2002-05-21 |
| HK1033281A1 (en) | 2001-08-24 |
| PL343936A1 (en) | 2001-09-10 |
| UA60364C2 (uk) | 2003-10-15 |
| DK1077703T3 (da) | 2003-06-23 |
| AU753482B2 (en) | 2002-10-17 |
| NZ507968A (en) | 2002-12-20 |
| EP1077703A1 (de) | 2001-02-28 |
| KR100587210B1 (ko) | 2006-06-08 |
| RU2226394C2 (ru) | 2004-04-10 |
| SK16772000A3 (sk) | 2001-05-10 |
| CA2325636A1 (en) | 1999-11-18 |
| HUP0101597A3 (en) | 2003-01-28 |
| HUP0101597A2 (hu) | 2001-11-28 |
| CN1300216A (zh) | 2001-06-20 |
| ATE235242T1 (de) | 2003-04-15 |
| WO1999058129A1 (de) | 1999-11-18 |
| ES2195573T3 (es) | 2003-12-01 |
| BR9910350A (pt) | 2001-09-25 |
| PE20000480A1 (es) | 2000-05-20 |
| ZA200006440B (en) | 2002-02-08 |
| MY118569A (en) | 2004-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR019279A1 (es) | Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion. | |
| DOP2022000124A (es) | Derivados de pirazolilo útiles como agentes anticancerígenos | |
| ES2141688B1 (es) | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. | |
| AP1445A (en) | Substituted 4-amino-thiazol-2-yl compounds as CDKs inhibitors. | |
| AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
| CY1105538T1 (el) | Ιατρικη μορφοποιηση αερολυματος | |
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| ECSP024341A (es) | Composiciones farmaceuticas | |
| UY27417A1 (es) | Compuestos bicíclicos aromáticos sustituidos con amino-alquilo, procedimiento para su preparación y su utilización como medicamentos | |
| MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
| AR055319A1 (es) | Derivados de isoquinoleina, composiciones farmaceuticas y usos | |
| ATE288759T1 (de) | Verwendung von stabilisierten oligonucleotiden zur herstellung von antitumoralen arzneimitteln | |
| ECSP034534A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| CY1108770T1 (el) | Νεα παραγωγα του ινδολιου και χρηση τους ως φαρμακων | |
| CL2015001086A1 (es) | Combinación farmacéutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas | |
| AR024462A1 (es) | Tabletas farmaceuticas | |
| BR112022003895A2 (pt) | Sistema e método de entrega de múltiplos fármacos | |
| PT1140031E (pt) | Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa | |
| TR200100895T2 (tr) | Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı | |
| UY26371A1 (es) | Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen | |
| CL2007002637A1 (es) | Compuestos derivados de acido 2-fenoxinicotinico; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de dislipidemias, arteriosclerosis e insuficiencia cardiaca. | |
| AR030712A1 (es) | Nuevos derivados de aminociclohexanol | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |